Atlas Trials

Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer

Clinical trial NCT00930475 · UNKNOWN

Trial details

NCT number
NCT00930475
Sponsor
Charite University, Berlin, Germany
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2009-02-01
Primary completion
2010-12-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.